Content - Research grants

Research Grants

  • SAKK / Dr. Paul Janssen Fellowship

    SAKK and Janssen-Cilag AG have decided to jointly award a fellowship endowed with CHF 30'000.-. The educational grant is aimed at offering young doctors the opportunity to spend up to four months at a renowned research center abroad to gain experience and acquire the necessary know-how and tools to develop and conduct top-quality clinical trials.

    SAKK / Dr. Paul Janssen Fellowship 2018 - The call for proposals is now open. Doctors in training for their specialization in Swiss hospitals, active in clinical cancer research, are herewith invited to apply for the educational grant. Applications can be sent to until April 30, 2018.

    Regulations SAKK / Dr. Paul Janssen Fellowship 2018

  • SAKK / Celgene Life Grant

    Pancreatic cancer remains a devastating disease associated with a poor survival prognosis and a significant impairment of the quality of life of patients and their relatives. SAKK and Celgene share a common interest in innovative research for life-changing medication and therapeutic concepts for patients with high unmet medical needs. The SAKK / Celgene Life Grant supports planned or ongoing research projects in pancreatic cancer care aiming to improve the quality of life of patients and their relatives.

    SAKK / Celgene Life Grant 2018 - The call for proposals is now open:

    Key information about the grant

    • Grant is endowed with CHF 20 000.–
    • Application deadline is April 30, 2018
    • Download the application form, rules and regulations here:
    • Submit your application online at


    • are a practicing physician, clinical researcher or professional in a patient care institution/society
    • have your primary place of research in Switzerland

    Your project

    • aims to reduce the burden of pancreatic cancer for patients and/or their relatives, thereby significantly improving their quality of life
    • is directly related to patient care
    • has a research nature (e.g. database/registry research, working and patient care models, QoL tools, etc.)
    • may focus on aspect such as interdisciplinary communication/collaboration, treatment support, end-of-life support, psychological/social aspects, etc.
    • is conducted in Switzerland
    • is planned or ongoing

    Grant winner

    An independent jury, chaired by the SAKK president Prof. Roger von Moos, evaluates all projects and announces the grant winner at the semi-annual SAKK meeting in June 2018, where he/she will be requested to present a short exposé on the planned research. Further notifications about the winning project will be published in the Schweizer Krebsbulletin, the SAKK newsletter and on this website.

  • SAKK / Amgen Research Grant

    SAKK and Amgen Switzerland AG award the SAKK / Amgen Research Grant every two years for outstanding and novel translational cancer research in Switzerland that improves patient’s lives. The grant is endowed with CHF 50'000.-.
    Researchers or a research team independent of their nationality and age, working at a Swiss hospital or institution can apply for the SAKK / Amgen research grant. The grant should contribute to an independent research project and cover a relevant scientific part of the project.

    The call for proposals for the SAKK / Amgen Research Grant 2017 is closed.

  • Call for applications: SAKK / Astellas GU-Oncology Award 2018

    To further preclinical and clinical oncology research in Switzerland, SAKK and Astellas team up to confer the Swiss GU-Oncology Award. A researcher will be awarded as representative of a research group or project for an outstanding scientific and/or clinical achievement documented by a scientific publication (published paper or accepted manuscript in a peer-reviewed journal).

    The focus of the SAKK / Astellas GU-Oncology Award lies on potential tangible improvements for patient management and outcomes in the treatment of genitourinary cancers.

    The award is endowed with CHF 30’000.- and should encourage the continuation of research activities. Hence the awarded sum is to be used for ongoing and future research within the respective research group or project.

    Call for applications

    Prior to your application, please carefully read the applicable Award Rules. Please send your applications until September 30, 2018. Full applications must be sent via e-mail to

  • SAKK / Pfizer Award

    SAKK and Pfizer AG (Switzerland) jointly award the SAKK / Pfizer Award endowed with CHF 20'000.- every two years. The award honors patient-oriented, practice-relevant research in clinical oncology.
    Medical professionals below the age of 50 are welcome to apply for the SAKK / Pfizer Award by submitting their research work in the form of a scientific publication. The manuscript must be either published within the last year or be submitted for publication in a peer-reviewed journal. The publication must directly contribute to the improvement of cancer treatment and patient outcome.

    The call for proposals for the SAKK / Pfizer Award 2017 is closed.

  • The RTFCCR / SAKK Research Grant

    Swiss Group for Clinical Cancer Research (SAKK) and the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) have joined forces for this unique opportunity to attract high quality clinical studies focusing on confirming the need of treatment.  

    Additional treatments can sometimes be more harmful than beneficial and are costly. Unnecessary treatments with undesirable side effects should therefore be avoided as it impairs patients’ quality of life significantly.  

    The call for proposals for the RTFCCR / SAKK Research Grant 2017 is closed.

Other information:

Flurina Hoffmann
SAKK Coordinating Center
Effingerstrasse 33
3008 Bern
+41 31 508 41 78